Filing Details

Accession Number:
0001681622-19-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-05 17:50:16
Reporting Period:
2019-11-01
Accepted Time:
2019-11-05 17:50:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1681622 Varex Imaging Corp VREX Electronic Components, Nec (3679) 813434516
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1695264 S. Mark Jonaitis C/O Varex Imaging Corp
1678 S. Pioneer Road
Salt Lake City UT 84104
Svp And Gm, X-Ray Sources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-01 13,530 $22.84 51,969 No 4 M Direct
Common Stock Disposition 2019-11-01 13,530 $31.02 38,439 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-11-01 13,530 $0.00 13,530 $22.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-11-09 No 4 M Direct
Footnotes
  1. Includes 939 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.
  2. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 20, 2019. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.19 to $31.39. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  3. These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.